Octagon Capital Advisors LP / SNDX
Octagon Capital Advisors LP’s Syndax Pharmaceuticals Inc Position
Does Octagon Capital Advisors LP own Syndax Pharmaceuticals Inc (SNDX)? Not currently — the last reported position was 904.0K shares worth $11M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q1 2025
Shares
904.0K
% of Portfolio
+2.15%
Quarters Held
2
position exited
Position History SNDX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of SNDX.